Clinical Trials
<ѻý>Droxidopa for OH Slammed by FDA Reviewersѻý>
SILVER SPRING, Md. -- Droxidopa (Northera) is getting a second look by an FDA advisory committee for the treatment of orthostatic hypotension stemming from neurological disorders like Parkinson's disease, but an agency review doesn't look promising for approval.
Jan 13, 2014
<ѻý>Sildenafil Trial Halted in Patients with Sickle Cell Diseaseѻý>
LITTLE FALLS, N.J. -- The National Heart, Lung, and Blood Institute has halted a trial of sildenafil (Revatio) in sickle cell patients with pulmonary hypertension because of increased hospitalizations for sickle cell crises, or severe pain, the agency said.
Jul 29, 2009